search
Back to results

Osteopathic Manipulative Medicine to Reduce Developmental Delays

Primary Purpose

Extreme Prematurity, Neurodevelopmental Abnormality

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Osteopathic Manipulative Medicine
Sponsored by
University of Rochester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Extreme Prematurity focused on measuring osteopathic manipulative medicine (OMM), test of infant motor performance (TIMP), neurodevelopmental outcomes

Eligibility Criteria

1 Day - 14 Weeks (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 23 0/7- 33 6/7 weeks' gestational age (GA) at birth, ≥28 0/7 weeks' GA at time of consent
  • stable enough to tolerate gentle manipulation

Exclusion Criteria:

  • > 33 6/7 weeks' GA at birth
  • known congenital and genetic abnormalities affecting neurodevelopment
  • known conditions requiring surgical intervention
  • severe intracranial hemorrhage or other severe neurologic complications
  • parents unable to read and understand English

Sites / Locations

  • Golisano Children's Hospital
  • University of Rochester

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

OMM

Control

Arm Description

Neonates randomized to receive osteopathic manipulation

Neonates randomized to receive standard care only

Outcomes

Primary Outcome Measures

Test of Infant Motor Performance (TIMP)
Standardized, validated assessment of risk for developmental delay; expected range: 20 - 90 with higher scores indicating less risk for developmental delay

Secondary Outcome Measures

Length of stay
Number of days in Neonatal Intensive Care Unit (NICU)
Growth parameters - weight
weight z-score
Growth parameters - length
length z-score
Growth parameters - head circumference
head circumference z-score
Need for nasogastric (NG), orogastric (OG), or gastrostomy tube feeds at discharge
Number of neonates requiring NG, OG, or gastrostomy feeds at discharge from NICU

Full Information

First Posted
November 25, 2020
Last Updated
August 11, 2023
Sponsor
University of Rochester
search

1. Study Identification

Unique Protocol Identification Number
NCT04652063
Brief Title
Osteopathic Manipulative Medicine to Reduce Developmental Delays
Official Title
Using Osteopathic Manipulative Medicine on Preterm Infants in the Neonatal Intensive Care Unit to Reduce Neuromotor Developmental Delays
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
January 5, 2021 (Actual)
Primary Completion Date
December 1, 2022 (Actual)
Study Completion Date
July 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Rochester

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This randomized clinical trial seeks to determine if osteopathic manipulative medicine (OMM) increases the likelihood of improved neurodevelopmental outcomes as estimated by the Test of Infant Motor Performance (TIMP).
Detailed Description
Hypothesis: High risk preterm infants born <34 weeks of gestation who receive OMM, compared to the standard supportive care, will have improved neuromotor development scores on the TIMP. Specific Aims and Objectives: Primary aim: To determine the difference in TIMP scores between infants who receive OMM and those who receive only standard neonatal intensive care unit (NICU) care. Secondary aims: To compare length of stay between infants who receive OMM and those who receive only standard NICU care. To compare growth parameters including weight, length, and head circumference, (both means and Z scores) prior to discharge between infants who receive OMM and those who receive only standard NICU care. To compare percentage of subjects requiring nasogastric, orogastric, or gastrostomy tube feeds at discharge between infants who receive OMM and those who receive only standard NICU care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Extreme Prematurity, Neurodevelopmental Abnormality
Keywords
osteopathic manipulative medicine (OMM), test of infant motor performance (TIMP), neurodevelopmental outcomes

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomization 1:1 to control and intervention group
Masking
Care ProviderOutcomes Assessor
Masking Description
The individual performing the developmental assessment will be unaware of study arm assignment
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
OMM
Arm Type
Experimental
Arm Description
Neonates randomized to receive osteopathic manipulation
Arm Title
Control
Arm Type
No Intervention
Arm Description
Neonates randomized to receive standard care only
Intervention Type
Other
Intervention Name(s)
Osteopathic Manipulative Medicine
Intervention Description
Osteopathic evaluation and treatment (gentle touch according to published protocols) will take about 15 - 20 minutes, and will be performed every 7 - 10 days during the infant's NICU stay once they reach at minimum of at least 28 weeks corrected gestational age and until they reach 36 weeks corrected gestational age.
Primary Outcome Measure Information:
Title
Test of Infant Motor Performance (TIMP)
Description
Standardized, validated assessment of risk for developmental delay; expected range: 20 - 90 with higher scores indicating less risk for developmental delay
Time Frame
At approximately 36 weeks' corrected gestational age
Secondary Outcome Measure Information:
Title
Length of stay
Description
Number of days in Neonatal Intensive Care Unit (NICU)
Time Frame
At NICU discharge, assessed up to 1 year
Title
Growth parameters - weight
Description
weight z-score
Time Frame
at 36 weeks' corrected gestational age and discharge
Title
Growth parameters - length
Description
length z-score
Time Frame
at 36 weeks' corrected gestational age and discharge
Title
Growth parameters - head circumference
Description
head circumference z-score
Time Frame
at 36 weeks' corrected gestational age and discharge
Title
Need for nasogastric (NG), orogastric (OG), or gastrostomy tube feeds at discharge
Description
Number of neonates requiring NG, OG, or gastrostomy feeds at discharge from NICU
Time Frame
at NICU discharge, assessed up to 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
14 Weeks
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 23 0/7- 33 6/7 weeks' gestational age (GA) at birth, ≥28 0/7 weeks' GA at time of consent stable enough to tolerate gentle manipulation Exclusion Criteria: > 33 6/7 weeks' GA at birth known congenital and genetic abnormalities affecting neurodevelopment known conditions requiring surgical intervention severe intracranial hemorrhage or other severe neurologic complications parents unable to read and understand English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ronnie Guillet, MD, PhD
Organizational Affiliation
University of Rochester
Official's Role
Principal Investigator
Facility Information:
Facility Name
Golisano Children's Hospital
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States
Facility Name
University of Rochester
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No plans to share HPI and data for individual participants at this time.
Citations:
PubMed Identifier
24904746
Citation
Cerritelli F, Martelli M, Renzetti C, Pizzolorusso G, Cozzolino V, Barlafante G. Introducing an osteopathic approach into neonatology ward: the NE-O model. Chiropr Man Therap. 2014 May 9;22:18. doi: 10.1186/2045-709X-22-18. eCollection 2014.
Results Reference
background
PubMed Identifier
23322391
Citation
Wang L, He JL, Zhang XH. The efficacy of massage on preterm infants: a meta-analysis. Am J Perinatol. 2013 Oct;30(9):731-8. doi: 10.1055/s-0032-1332801. Epub 2013 Jan 15.
Results Reference
background
PubMed Identifier
25974071
Citation
Cerritelli F, Pizzolorusso G, Renzetti C, Cozzolino V, D'Orazio M, Lupacchini M, Marinelli B, Accorsi A, Lucci C, Lancellotti J, Ballabio S, Castelli C, Molteni D, Besana R, Tubaldi L, Perri FP, Fusilli P, D'Incecco C, Barlafante G. A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms. PLoS One. 2015 May 14;10(5):e0127370. doi: 10.1371/journal.pone.0127370. eCollection 2015.
Results Reference
background
PubMed Identifier
18300928
Citation
Campbell SK, Swanlund A, Smith E, Liao PJ, Zawacki L. Validity of the TIMPSI for estimating concurrent performance on the test of infant motor performance. Pediatr Phys Ther. 2008 Spring;20(1):3-10. doi: 10.1097/PEP.0b013e31815f66a6.
Results Reference
background

Learn more about this trial

Osteopathic Manipulative Medicine to Reduce Developmental Delays

We'll reach out to this number within 24 hrs